SG/PUT/STRYKER CORP./250/0.1/21.06.24 Stock

Warrant

DE000SV4MRX5

Delayed Deutsche Boerse AG 09:03:46 2024-05-20 am EDT
0.001 EUR 0.00% Intraday chart for SG/PUT/STRYKER CORP./250/0.1/21.06.24
3 months-98.73%
6 months-99.86%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-20 0.001 0.00%
24-05-17 0.001 0.00%
24-05-16 0.001 0.00%
24-05-15 0.001 0.00%
24-05-14 0.001 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 09:03 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SV4MRX
ISINDE000SV4MRX5
Date issued 2023-04-21
Strike 250 $
Maturity 2024-06-21 (32 Days)
Parity 10 : 1
Emission price 1.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.96
Lowest since issue 0.001
Spread 0.119
Spread %99.17%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.7 USD
Average target price
372.4 USD
Spread / Average Target
+11.26%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW